1. Home
  2. SGHT vs SMTI Comparison

SGHT vs SMTI Comparison

Compare SGHT & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$5.43

Market Cap

309.6M

Sector

Health Care

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$24.55

Market Cap

208.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
SMTI
Founded
2011
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
309.6M
208.2M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
SGHT
SMTI
Price
$5.43
$24.55
Analyst Decision
Buy
Strong Buy
Analyst Count
7
2
Target Price
$9.08
$34.00
AVG Volume (30 Days)
175.8K
57.3K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
28.16
N/A
EPS
N/A
0.05
Revenue
$77,363,000.00
$15,586,976.00
Revenue This Year
$11.67
$17.31
Revenue Next Year
$10.39
$12.48
P/E Ratio
N/A
$496.80
Revenue Growth
N/A
32.47
52 Week Low
$3.11
$16.05
52 Week High
$9.24
$35.70

Technical Indicators

Market Signals
Indicator
SGHT
SMTI
Relative Strength Index (RSI) 58.13 62.65
Support Level $4.76 $20.47
Resistance Level $5.66 $26.48
Average True Range (ATR) 0.36 1.38
MACD 0.02 0.21
Stochastic Oscillator 56.86 97.59

Price Performance

Historical Comparison
SGHT
SMTI

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: